Trade

with

Edap TMS SA
(NASDAQ: EDAP)
AdChoices
1.47
+0.07
+5.00%
After Hours :
-
-
-

Open

1.45

Previous Close

1.40

Volume (Avg)

108.87k (514.64k)

Day's Range

1.45-1.54

52Wk Range

1.15-6.05

Market Cap.

36.44M

Dividend Rate ( Yield )

-

Beta

2.05

Shares Outstanding

24.79M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Devices
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 30.67M

    • Net Income

    • -6.40M

    • Market Cap.

    • 36.44M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -19.85

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 2.05

    • Forward P/E

    • 116.28

    • Price/Sales

    • 0.94

    • Price/Book Value

    • 2.52

    • Price/Cash flow

    • -32.15

      • EBITDA

      • -3.57M

      • Return on Capital %

      • -18.04

      • Return on Equity %

      • -50.67

      • Return on Assets %

      • -18.04

      • Book Value/Share

      • 0.75

      • Shares Outstanding

      • 24.79M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Buy
        • 1 Year Price Target

        • 5.74

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • 0.00

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 25.10

          • 2.66

          • Net Income

            YTD/YTD (last year)

          • -

          • -22.64

          • Net Income

            Q/Q (last year)

          • -

          • -29.83

          • Sales (Revenue)

            5-Year Annual Average

          • 0.88

          • 4.60

          • Net Income

            5-Year Annual Average

          • -

          • -1.34

          • Dividends

            5-Year Annual Average

          • -

          • -0.25

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 40.15

            • 64.08

            • Pre-Tax Margin

            • -19.44

            • 15.19

            • Net Profit Margin

            • -19.85

            • 13.09

            • Average Gross Margin

              5-Year Annual Average

            • 40.20

            • 65.03

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -26.30

            • 17.99

            • Average Net Profit Margin

              5-Year Annual Average

            • -27.70

            • 191.75B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.07

              • 0.34

              • Current Ratio

              • 1.91

              • 2.55

              • Quick Ratio

              • 1.47

              • 1.83

              • Interest Coverage

              • -

              • 11.70

              • Leverage Ratio

              • 2.89

              • 1.86

              • Book Value/Share

              • 0.58

              • 11.69

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -4.33

                • 32.79

                • P/E Ratio 5-Year High

                • -22.67

                • 224.03

                • P/E Ratio 5-Year Low

                • -3.74

                • 60.23

                • Price/Sales Ratio

                • 0.86

                • 3.07

                • Price/Book Value

                • 2.31

                • 3.10

                • Price/Cash Flow Ratio

                • -32.15

                • 17.86

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -50.67

                        (-65.50)

                      • 12.33

                        (18.16)

                      • Return on Assets %

                        (5-Year Average)

                      • -18.04

                        (-19.20)

                      • 6.62

                        (8.69)

                      • Return on Capital %

                        (5-Year Average)

                      • -39.66

                        (-37.10)

                      • 8.49

                        (11.48)

                      • Income/Employee

                      • -

                      • 34.11k

                      • Inventory Turnover

                      • 3.18

                      • 2.77

                      • Asset Turnover

                      • 0.91

                      • 0.51

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -3.51M
                      Operating Margin
                      -11.44
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -32.15
                      Ownership

                      Institutional Ownership

                      20.12%

                      Top 10 Institutions

                      19.57%

                      Mutual Fund Ownership

                      9.71%

                      Float

                      -

                      5% / Insider Ownership

                      -

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Bruce Fund

                      •  

                        1,113,694

                      • 0.00

                      • 4.49

                      • PSM Growth UI

                      •  

                        644,781

                      • 3.09

                      • 2.60

                      • PSM Value Strategy UI

                      •  

                        548,008

                      • -50.56

                      • 2.21

                      • Perkins Discovery Fund

                      •  

                        40,000

                      • 0.00

                      • 0.16

                      • Fidelity® NASDAQ Composite Index® Fund

                      •  

                        1,813

                      • 0.00

                      • 0.01

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Bruce & Co Inc

                      •  

                        1,565,494

                      • 0.00%

                      • 6.31

                      • Universal-Investment GmbH

                      •  

                        1,192,789

                      • -31.21%

                      • 4.81

                      • Perkins Capital Management Inc

                      •  

                        603,900

                      • +6.11%

                      • 2.44

                      • Professional Life & Casualty Company

                      •  

                        347,786

                      • 0.00%

                      • 1.60

                      • Wells Capital Management Inc.

                      •  

                        291,088

                      • +10.85%

                      • 1.17

                      • Susquehanna Financial Group, LLLP

                      •  

                        60,039

                      • +120.98%

                      • 0.24

                      • PSM Vermögensverwaltung GmbH

                      •  

                        59,272

                      • -1.21%

                      • 0.27

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Devices

                      Type

                      Slow Growth

                      Style

                      Small Value

                      EDAP TMS SA was incorporated on December 3, 1979 as a Societe Anonyme organized under the laws of the Republic of France for 60 years from the date of incorporation. It is a holding Company and is responsible for providing common ser...morevices to its subsidiaries, including preparation and consolidation of the financial statements for the group, complying with the requirements of various regulatory agencies and maintaining the listing of its publicly held securities. Its activity is organized in two divisions: HIFU and UDS. Through these two divisions, the Company develops, produces and markets minimally invasive medical devices, mainly for urological diseases. It's HIFU and UDS divisions operate in Europe, the Americas, Asia and the rest of the world. The HIFU division is engaged in the development, ma...morenufacturing and marketing of medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. Its HIFU business is quite seasonal and generally linked to lengthy hospital decision and investment processes. In addition to developing, manufacturing and marketing HIFU devices, the HIFU division also generates revenues from leasing equipment, as well as from the sale of disposables, spare parts and maintenance services. Currently, the only commercial product of the Company utilizing HIFU technology is the Ablatherm, an ultrasound guided HIFU device for the treatment of organ-confined prostate cancer. As of December 31, 2013, the HIFU division’s patent portfolio contained 36 patents consisting of 16 in the United States, 18 in the European Union and Japan and 2 in Israel and the rest of the world. They belong to 18 groups of patents covering key technologies related to therapeutic ultrasound principles, systems and associated software. The UDS division's main business is producing and marketing devices, known as lithotripters, for the treatment of urinary tract stones by means of ESWL technology. In addition to its manufacturing and selling of lithotripters, the UDS division also generates revenues from the leasing of lithotripters, as well as from the sale of disposables, spare parts and maintenance services. The UDS division offers the Sonolith i-move to small and mid-size hospitals, while the Sonolith i-sys is offered to large hospitals that can afford a fully dedicated and integrated lithotripter. Ablatherm-HIFU device competes with all current treatments for localized tumors, which include surgery, brachytherapy, radiotherapy, cryotherapy and hormonotherapy. The Company and its products are regulated in the United States by the FDA under a number of statutes including the Federal Food, Drug and Cosmetic Act.lessless

                      Key People

                      Marc Oczachowski

                      CEO/President, Subsidiary

                      Philippe Chauveau

                      Chairman of the Board/Director

                      Eric Soyer

                      CFO/Managing Director, Divisional

                      Dr. Argil J. Wheelock,M.D.

                      Director

                      Pierre Beysson

                      Director

                      • Edap TMS SA

                      • Parc d'Activites La Poudrette Lamartine

                      • Vaulx-en-Velin, 69120

                      • FRA.Map

                      • Phone: +33 472153150

                      • Fax: -

                      • edap-tms.com

                      Incorporated

                      1979

                      Employees

                      154

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: